Completing Chemo Vital for Patients with Small-Cell Lung Cancer
In patients with limited-stage, small-cell lung cancer being treated with chemotherapy, survival is not affected if thoracic radiotherapy is administered early or later in the course of chemotherapy (cycle 2 versus cycle 6), results of a British study suggest. Far more relevant, the investigators observed, is that patients do markedly better when they receive the entire dose of chemotherapy.
This entry was posted on Thursday, August 31st, 2006 at 2:39 pm and is filed under Research, Small-Cell. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.